Precipio Q4 2025 Preliminary Revenue $6.7M, An Increase Of 23% From $5.4M YoY
Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), announces some preliminary (unaudited) financials for Q4-2025 and for its fiscal year 2025.Below are some of the key financial performance metrics